480
Participants
Start Date
June 28, 2024
Primary Completion Date
March 30, 2025
Study Completion Date
December 30, 2025
A noninvasive cfDNA multi-omics assay
Peripheral venous blood samples will be collected from pancreatic cancer patients, individuals with precancerous lesions, and healthy controls. Subsequently, cfDNA will be extracted and subjected to low-pass whole genome sequencing (LP-WGS) and hybrid capture-based targeted methylation sequencing (TMS).
RECRUITING
Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University; 270 Dong An Road, Shanghai 200032, China, Shanghai
Nanjing Simcere Medical Laboratory Science Co., Ltd.
UNKNOWN
Fudan University
OTHER